Gene Therapy as a New Emerging Strategy for Prostate Cancer

Samaneh Adelian; Amin Soltani; Michael R Hamblin

doi:10.1007/978-981-97-4612-5_13

Back

Shared by

Michael R Hamblin

Gene Therapy as a New Emerging Strategy for Prostate Cancer

Chapter In A Book 2024 en

Authors

SA
Samaneh Adelian
AS
Amin Soltani
Michael R Hamblin

Related publications

Article2019

PARP inhibitor and CX-5461 combination therapy as a novel treatment strategy for castrate-resistant prostate cancer

Laura H. Porter, Mitchell G. Lawrence, Nicholas Choo, Shahneen Sandhu, Hong Wang, David Pook, Elaine Sanij, Richard B. Pearson, Ross D. Hannan, Luc Furic, Renea A. Taylor, Gail P. Risbridger

Discussion(0)

Sign in to like and join the discussion.

No comments yet. Be the first to comment.

Article

2022

Gene Therapy: An emerging therapeutic approach

Sravan Kumar Pasumarthi, Amit Khurana, Ralf Weiskirchen

Article2021

Targeted radioactive therapy for prostate cancer reply

Michael S. Hofman, Shahneen Sandhu, Roslyn J. Francis, Ian D. Davis, Louise Emmett

Article2016

Abstract 5181: Dual inhibition of RNA Pol I transcription and PIM kinase as a new therapy to treat prostate cancer

Richard J. Rebello, Eric Kusnadi, Donald P. Cameron, Analia Lesmana, Denis Drygin, Ashlee K. Clark, Laura H. Porter, Shahneen Sandhu, Gail P. Risbridger, Richard B. Pearson, Ross D. Hannan, Luc Furic

Article2013

The nucleolus: an emerging target for cancer therapy

Nadine Hein, Katherine M. Hannan, Amee J. George, Elaine Sanij, Ross D. Hannan